Vivoryon Therapeutics Company
%20.jpg)
Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.
Total Funding:
$5M
Headquarters:
Halle An Der Saale, Sachsen-Anhalt, Germany
Funding Status:
IPO
Employee Number:
101-250
Estimated Revenue:
$1M to $10M
Last Funding Type:
Private Equity
Technology:
Geroscience
Investor Type:
For Profit
Investors Number:
1
Founded Date:
1-1
Industry:
Biotechnology, Health Care, Science and Engineering